Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.07% Nasdaq Down0.78%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
67.00 Down 1.30(1.90%) 3:47PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 22, 2014Pechala's ReportsLubomir PechalaVERTEX PHARMACEUTICALS INC (VRTX) - REPORT FOR ACTIVE TRADERS1$25
Apr 22, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49
Apr 22, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Vertex Pharmaceuticals Inc42$75
Apr 22, 2014New Constructs, LLCN/AVRTX: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 18, 2014S&P Capital IQ – STARS ReportsN/AVertex Pharmaceuticals11$126.50
Apr 18, 2014Stock Traders DailyThomas H Kee Jr.Trading Report for (VRTX). A detailed report, including free correlated market analysis, and updates.10$20
Apr 18, 2014Stock Traders DailyThomas H Kee Jr.Our Economy without Stimulus; forward observations.102$20
Apr 18, 2014Pechala's ReportsFrantisek PechalaVERTEX PHARMACEUTICALS INC (VRTX) 12-months forecast1$15
Apr 17, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VERTEX PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for VRTX11$25

View All Reports for VRTX ...